Miguel Angel Avila

General director

Miguel Ángel is an Engineer, MBA and R&D manager with GESTIDI certification. He has previously managed and coordinated 25 national and 4 FP7 projects at R&D companies such as Oblanca (Spain). He was also the founder of Spanish companies Thermolabel Technology and La Era, which were successfully exited.

Mario Grande Abascal

Corporate director

Mario has over 15 years of experience as Venture Builder in Multinationals of the Pharma industry speeding up business and defining and executing the strategy

Dra. Maria Sola Gil

Corporate strategy director

María is a Biotechnologist holding a MSc. in Research, Development & innovation in New Drugs.  She gives the team more than 10 years in the Pharma and Biotech Corporate Arena managing the successful Development and Launch of a range of products including cosmetics, small molecules and biosimilars.

Claudio Santos

Chief Business Officer

Cláudio has a BSc and PhD in Biology. Previously he worked as a Technology Transfer Manager at Cancer Research Technology (UK), as a life sciences venture capital investor at Sixth Element Capital (UK) and as Chief Business Officer at Bioncotech Therapeutics (Spain).

Álvaro Sanz

Manager (“CFO”)

Álvaro is a graduate in Business Administration with over 20 years of experience in SME business administration. He has a track record of leading M&A operations. At Neurofix, he is responsible for administration, financial control and accountancy.

Daniel Bermejo

Clinical Trial Coordinator

Daniel is a BSc and MRes in Biology with extensive experience in data and project management and in clinical development gained at Spanish companies such as Farmalider Group, Fina Biotech, PharmaMar and Sermes.

Dr. Ignácio Galicia

Clinical Advisor

Ignácio is an MD and Clinical Pharmacologist, who is currently the Director of Clinical Research at Institute Fundación Teófilo Hernando (Madrid, Spain). Previously, he was the leader of Clinical Research at Hospital La Paz (Madrid, Spain) and the Director of the Clinical Trial Unit at Hospital Gómez Ulla (Madrid, Spain).

Professor Pablo Escribá

Scientific Advisor

Pablo is a Professor at the University of Illes Balears. He has over 30 years of biomedical research experience and is the author of 6 patents licenced to biotech companies and over 100 scientific publications.

Luisa Segura


Management and design of the pharmaceutical development of the investigational medicinal drug product. Coordination of the different stages of the scale up, manufacture and quality control of the investigational medicinal drug product. Preparation of the Investigational Medicinal Product Dossier.

Jose Javier Muruzabal

galenica director

DIrector in galenica jobs, more than 25 years of experience in similar projects.